

  • Topics
    • Mobile
    • Laptop/Pc
    • Smart Home
    • Audio
    • Games
  • Trending
  • News
    • Pr Newswire
    • Globe Newswire
  • Best Pick
  • Reviews
  • How To Do
  • 
  • 
  • Log in

    
    or

    Don't you have an account yet? Register

  • VN
  • EN


  •  Home
  •  Videos
  •  Posts
  •  Contact
 11-12-2022, 20:59

JITC publication of Akeso's Ligufalimab(CD47 monoclonal antibody) mechanism shows promising antitumor efficacy and favorable safety profile

Lộc Tạ

Popular Posts
  • Databricks Releases Final Keynote Lineup and Industry Programming for 2022 Data + AI Summit

    likes . 0 comments
  • Supporting the Low-carbon Development of Automotive Industry, GWM Opens Over 1,000 New Energy Vehicle Patents

    likes . 0 comments
  • GE Fair Fund to Compensate Certain Investors in General Electric Company Common Stock

    likes . 0 comments
  • Fosun's Innovative Achievements Continue to Make Breakthroughs

    likes . 0 comments
  • EV Connect Acquired by Schneider Electric to Accelerate EV Revolution

    likes . 0 comments

Email: info@vietsoftgroup.com

Trangcongnghe.com is part of VSG Solution JSC, an international media group and leading digital publisher.

© 2021 - Trangcongnghe.com All Rights Reserved.